Excessive testing may be compromising T2DM care

Excessive testing may be compromising T2DM care

(HealthDay)—Many Americans with type 2 diabetes may be getting unnecessary tests—and, in some cases, needless changes in medication, according to a study published online Dec. 8 in The BMJ.

The study's findings are based on made between 2001 and 2013 for 31,545 type 2 age 18 and older. All of the adults in the study had glycated hemoglobin (HbA1c) levels that were consistently below 7 percent within the previous two years.

Nearly 55 percent underwent HbA1c tests three or four times per year. Another 6 percent had at least five tests per year. Frequent HbA1c tests were also associated with increased odds that patients would be started on additional medications to control their glucose levels.

"I think part of the problem is that we often think more testing is better," lead researcher Rozalina McCoy, M.D., a professor of medicine at the Mayo Clinic in Rochester, Minn., told HealthDay.

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: British Medical Journal (BMJ)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Excessive testing may be compromising T2DM care (2015, December 10) retrieved 19 April 2024 from https://medicalxpress.com/news/2015-12-excessive-compromising-t2dm.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Overtesting for diabetes patients reaps negative rewards

0 shares

Feedback to editors